Monitoring serum beta-2 microglobulin is useful for detecting patients with increased risk of acute rejection during reduction in immunosuppression.
Câmara
N O
NO
Department of Medicine, Federal University of São Paulo, Brazil.
Nishida
S
S
Silva
M S
MS
Pestana
J O
JO
Pereira
A B
AB
Sesso
R
R
Pacheco-Silva
A
A
D000208:Acute Disease; D000704:Analysis of Variance; D016001:Confidence Intervals; D003404:Creatinine / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006084:Graft Rejection / Q000097:blood / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008991:Monitoring, Physiologic; D016017:Odds Ratio; D012044:Regression Analysis; D018570:Risk Assessment; D012307:Risk Factors; D001613:beta 2-Microglobulin / Q000032:analysis*
D001613:beta 2-Microglobulin; D003404:Creatinine